NCT05847010

Brief Summary

In the course of a scientific accompanying program, the project pursues the goal of gaining further insight into a possible connection between various influencing factors and the development of postoperative delirium. Against this background, in addition to the primary goal of exploring delirium rates, we aim to identify associations between other secondary end goals like the internal circadian time or the heart rate variability and the occurrence of postoperative delirium. For this purpose, patients of the QC-POD (NCT04355195) sample will be studied.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

June 22, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

January 23, 2025

Status Verified

January 1, 2025

Enrollment Period

2 years

First QC Date

April 14, 2023

Last Update Submit

January 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of postoperative Delirium

    Incidence of postoperative delirium in all postoperative patients in normal ward, intensive care unit and recovery room with a validated delirium screening tool at two points in time.

    Up to the fifth postoperative day

Secondary Outcomes (12)

  • Duration of Delirium

    The participants are followed up until the end of hospital stay, an expected average of 7 days

  • Bodytime

    Before surgery

  • Chronotype 1

    Up to three months

  • Chronotype 2

    Up to three months

  • Heart rate variability 1

    The participants are followed up until the end of hospital stay, an expected average of 7 days.

  • +7 more secondary outcomes

Other Outcomes (3)

  • Proteomics

    At the morning of surgery

  • Metabolomics

    At the morning of surgery

  • Bodytime

    At the morning of surgery

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients aged ≥70 years, male and female, who are receiving surgery

You may qualify if:

  • Age ≥ 70 years
  • Male and female patients
  • Patients who have been included in QC-POD
  • surgery (elective and not elective)

You may not qualify if:

  • Moribund patients (palliative situation)
  • Insufficient knowledge of the German language
  • Cardiac arrhythmia (e.g. atrial fibrillation)
  • Presence of a pacemaker
  • Condition after heart transplantation
  • Inflammation in the area of the frontal sinus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anaesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum (CVK) and Campus Charite Mitte (CCM), Charite - Universitätsmedizin Berlin

Berlin, 13353, Germany

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood samples (monocytes and Cholinesterase activity)

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Claudia Spies, MD, Prof.

    Charite University, Berlin, Germany

    STUDY DIRECTOR

Central Study Contacts

Claudia Spies, MD, Prof.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Department of Anesthesiolgy and Intensive Care Medicine CC07

Study Record Dates

First Submitted

April 14, 2023

First Posted

May 6, 2023

Study Start

June 22, 2023

Primary Completion

July 1, 2025

Study Completion

September 1, 2025

Last Updated

January 23, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations